Zobrazeno 1 - 10
of 283
pro vyhledávání: '"Penny HL"'
Autor:
Dorff T; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California., Horvath LG; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, Australia., Autio K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Bernard-Tessier A; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Rettig MB; Departments of Medicine and Urology, University of California, Los Angeles, California.; Department of Medicine, VA Greater Los Angeles, Los Angeles, California., Machiels JP; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Bilen MA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Amgen Inc., Thousand Oaks, California., Adra N; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana., Rottey S; Department of Medical Oncology. Drug Research Unit, Ghent University, Ghent, Belgium., Greil R; Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-CCCIT and Cancer Cluster Salzburg, Salzburg, Austria., Matsubara N; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan., Tan DSW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Wong A; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Uemura H; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan., Lemech C; Scientia Clinical Research, University of New South Wales, Randwick, Australia., Meran J; Department of Internal Medicine, Hematology, and Internal Oncology, Hospital Barmherzige Brueder, Vienna, Austria., Yu Y; Global Biostatistical Science, Amgen Inc., Thousand Oaks, California., Minocha M; Clinical Pharmacology M&S, Amgen Inc., Thousand Oaks, California., McComb M; Clinical Pharmacology M&S, Amgen Inc., Thousand Oaks, California., Penny HL; Clinical Immunology, Amgen Inc., Thousand Oaks, California., Gupta V; Clinical Biomarkers, Amgen Inc., Thousand Oaks, California., Hu X; Clinical Biomarkers, Amgen Inc., Thousand Oaks, California., Jurida G; Safety TA & Combination Products, Amgen Inc., Thousand Oaks, California., Kouros-Mehr H; Global Development, Amgen Inc., Thousand Oaks, California., Janát-Amsbury MM; Early Development, Oncology, Amgen Inc., Thousand Oaks, California., Eggert T; Early Development, Oncology, Amgen Inc., Thousand Oaks, California., Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 15; Vol. 30 (8), pp. 1488-1500.
Autor:
Kelly WK; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania.; Sarah Cannon Research Institute, Nashville, Tennessee., Danila DC; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., Lin CC; National Taiwan University Hospital, Taipei, Taiwan., Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Matsubara N; National Cancer Center Hospital East, Chiba, Japan., Ward PJ; Sarah Cannon Research Institute, Nashville, Tennessee.; Oncology Hematology Care, Cincinnati, Ohio., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina., Pook D; Monash Health, Clayton, Victoria, Australia., Kim M; Seoul National University Hospital, Seoul, South Korea., Dorff TB; City of Hope, Duarte, California., Fischer S; Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Lin YC; Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan., Horvath LG; Chris O'Brien Lifehouse, University of Sydney, Sydney, New South Wales, Australia., Sumey C; Sanford Cancer Center, Sioux Falls, South Dakota., Yang Z; Amgen Inc., Thousand Oaks, California., Jurida G; Amgen Inc., Thousand Oaks, California., Smith KM; Amgen Inc., South San Francisco, California., Connarn JN; Amgen Inc., South San Francisco, California., Penny HL; Amgen Inc., Thousand Oaks, California., Stieglmaier J; Amgen Research (Munich) GmbH, Munich, Germany., Appleman LJ; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Jan 12; Vol. 14 (1), pp. 76-89.
Autor:
Penny HL; Department of Clinical Immunology, Amgen, Thousand Oaks, CA, United States., Hainline K; Department of Clinical Immunology, Amgen, Thousand Oaks, CA, United States., Theoharis N; Labcorp, Translational Biomarker Solutions, Greenfield, IN, United States., Wu B; Department of Biologics, Amgen, Thousand Oaks, CA, United States., Brandl C; Department of Translational Safety & Bioanalytical Sciences, Amgen Research (Munich) GmbH, Munich, Germany., Webhofer C; Department of Process Development, Amgen Research (Munich) GmbH, Munich, Germany., McComb M; Department of Clinical Pharmacology, Modeling & Simulation, Amgen, Thousand Oaks, CA, United States., Wittemer-Rump S; Bayer AG, Research and Development Oncology (RED Onc), Pharmaceuticals, Berlin, Germany., Koca G; Bayer AG, Research and Development Oncology (RED Onc), Pharmaceuticals, Berlin, Germany., Stienen S; Department of Early Development (Oncology), Amgen Research (Munich) GmbH, Munich, Germany., Bargou RC; Translational Oncology/Early Clinical Trial Unit (ECTU), Comprehensive Cancer Center Mainfranken, University Hospital Wurzburg, Wurzburg, Germany., Hummel HD; Translational Oncology/Early Clinical Trial Unit (ECTU), Comprehensive Cancer Center Mainfranken, University Hospital Wurzburg, Wurzburg, Germany., Loidl W; Department of Urology, Ordensklinikum Linz GmbH, Linz, Austria., Grüllich C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Medical Center, Heidelberg, Germany., Eggert T; Department of Early Development (Oncology), Amgen, Thousand Oaks, CA, United States., Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Mytych DT; Department of Clinical Immunology, Amgen, Thousand Oaks, CA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Oct 23; Vol. 14, pp. 1261070. Date of Electronic Publication: 2023 Oct 23 (Print Publication: 2023).
Autor:
Sieow JL; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore., Penny HL; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore., Gun SY; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore., Tan LQ; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore., Duan K; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore., Yeong JPS; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore 169856, Singapore., Pang A; Department of Haematology-Oncology, National University Cancer Institute, Singapore 119228, Singapore., Lim D; Department of Pathology, National University Health System, Singapore 119074, Singapore., Toh HC; Department of Oncology, National Cancer Centre, Singapore 169610, Singapore., Lim TKH; Department of Anatomical Pathology, Singapore General Hospital, Singapore 169856, Singapore., Engleman E; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Rotzschke O; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore., Ng LG; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore., Chen J; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore., Tan SM; School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore., Wong SC; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 01; Vol. 24 (1). Date of Electronic Publication: 2023 Jan 01.
Autor:
Penny HL; University of Pittsburgh Medical Center; Director of Blair Medical Associates, UPMC Wound Clinic, Altoona, PA, US.
Publikováno v:
Journal of wound care [J Wound Care] 2022 May 01; Vol. 31 (Sup5), pp. S3-S4.
Autor:
Zhou Y; Clinical Immunology, Amgen Inc, South San Francisco, California, USA yanchenz@amgen.com., Penny HL; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA., Kroenke MA; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA., Bautista B; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA., Hainline K; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA., Chea LS; Clinical Immunology, Amgen Inc, South San Francisco, California, USA., Parnes J; Early Development, Amgen Inc, Thousand Oaks, California, USA., Mytych DT; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Apr; Vol. 10 (4).
Autor:
Ducret A; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Ackaert C; ImmunXperts SA (A Nexelis Group Company), Gosselies, Belgium., Bessa J; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Bunce C; Abzena, Babraham Research Campus, Cambridge, UK., Hickling T; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Jawa V; Biotherapeutics and Bioanalysis Non-Clinical Development, Bristol Myers Squibb, Princeton, NJ, USA., Kroenke MA; Clinical Immunology-Translational Medicine, Amgen Inc, Thousand Oaks, CA, USA., Lamberth K; Analysis & Characterisation, Global Research Technologies, Novo Nordisk A/S, Måløv, Denmark., Manin A; Abzena, Babraham Research Campus, Cambridge, UK., Penny HL; Clinical Immunology-Translational Medicine, Amgen Inc, Thousand Oaks, CA, USA., Smith N; Lonza Biologics, Chesterford Research Park, Saffron Walden, UK., Terszowski G; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Tourdot S; BioMedicine Design, Pfizer Inc, Andover, MA, USA., Spindeldreher S; Integrated Biologix GmbH, Basel, Switzerland.
Publikováno v:
MAbs [MAbs] 2022 Jan-Dec; Vol. 14 (1), pp. 1993522.
Autor:
Penny HL; University of Pittsburgh Medical Center, Altoona, PA, US., Galiano RD; Division of Plastic and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, US.
Publikováno v:
Journal of wound care [J Wound Care] 2021 Nov 02; Vol. 30 (11), pp. 884-886.
Autor:
Penny HL; University of Pittsburgh Medical Center, Altoona, PA, US.
Publikováno v:
Journal of wound care [J Wound Care] 2021 Nov 02; Vol. 30 (11), pp. 888-889.
Autor:
Penny HL; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Sieow JL; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Gun SY; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Lau MC; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Lee B; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Tan J; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Phua C; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Toh F; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Nga Y; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Yeap WH; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Janela B; Skin Research Institute of Singapore (SRIS), 11 Mandalay Road, #17-01 Clinical Sciences Building, Singapore 308232, Singapore., Kumar D; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Chen H; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Yeong J; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Kenkel JA; Department of Pathology, Stanford University School of Medicine, 3373 Hillview Ave., Palo Alto, CA 94304, USA., Pang A; National University Cancer Institute Singapore, NUH Medical Centre (NUHMC) @ Levels 8-10, 5 Lower Kent Ridge Road, Singapore 119074, Singapore., Lim D; Department of Pathology, National University Health System, National University Hospital, Lower Kent Ridge Road, 1 Main Building, Level 3, Singapore 119074, Singapore., Toh HC; National Cancer Centre, 11 Hospital Crescent, Singapore 169610, Singapore., Hon TLK; Division of Pathology, Singapore General Hospital, 20 College Road, Academia, Level 7, Singapore 169856, Singapore., Johnson CI; Perkin Elmer Australia, 530-540 Springvale Road, Melbourne VIC 3150, Australia., Khameneh HJ; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Mortellaro A; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Engleman EG; Department of Pathology, Stanford University School of Medicine, 3373 Hillview Ave., Palo Alto, CA 94304, USA., Rotzschke O; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Ginhoux F; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Abastado JP; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Chen J; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore., Wong SC; Singapore Immunology Network, A*STAR, Singapore, 8A Biomedical Grove Level 3 & 4 Immunos Building, Singapore 138648, Singapore.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 Jun 14; Vol. 22 (12). Date of Electronic Publication: 2021 Jun 14.